4/2
05:28 pm
eypt
Form 4 EyePoint Pharmaceuticals For: Mar 30 Filed by: Paggiarino Dario A.
Low
Report
Form 4 EyePoint Pharmaceuticals For: Mar 30 Filed by: Paggiarino Dario A.
3/8
01:54 pm
eypt
Form 10-K EyePoint Pharmaceuticals For: Dec 31
Low
Report
Form 10-K EyePoint Pharmaceuticals For: Dec 31
3/7
07:05 am
eypt
Form 8-K EyePoint Pharmaceuticals For: Mar 07
Medium
Report
Form 8-K EyePoint Pharmaceuticals For: Mar 07
3/4
05:41 pm
eypt
Form 4 EyePoint Pharmaceuticals For: Mar 01 Filed by: Ribeiro Ramiro
Low
Report
Form 4 EyePoint Pharmaceuticals For: Mar 01 Filed by: Ribeiro Ramiro
3/4
05:38 pm
eypt
Form 3 EyePoint Pharmaceuticals For: Mar 01 Filed by: Ribeiro Ramiro
Low
Report
Form 3 EyePoint Pharmaceuticals For: Mar 01 Filed by: Ribeiro Ramiro
3/4
07:02 am
eypt
Form 8-K EyePoint Pharmaceuticals For: Mar 04
Medium
Report
Form 8-K EyePoint Pharmaceuticals For: Mar 04
2/28
05:04 pm
eypt
Form 4 EyePoint Pharmaceuticals For: Feb 27 Filed by: Duker Jay S.
Low
Report
Form 4 EyePoint Pharmaceuticals For: Feb 27 Filed by: Duker Jay S.
2/22
05:09 pm
eypt
Form 4 EyePoint Pharmaceuticals For: Feb 20 Filed by: Duker Jay S.
Low
Report
Form 4 EyePoint Pharmaceuticals For: Feb 20 Filed by: Duker Jay S.
2/14
09:09 pm
eypt
Form SC 13G/A EyePoint Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, L.P.
Medium
Report
Form SC 13G/A EyePoint Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, L.P.
2/14
10:04 am
eypt
Form SC 13G EyePoint Pharmaceuticals Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Medium
Report
Form SC 13G EyePoint Pharmaceuticals Filed by: PRICE T ROWE ASSOCIATES INC /MD/
2/13
05:41 pm
eypt
Form 4 EyePoint Pharmaceuticals For: Feb 09 Filed by: Lurker Nancy
Low
Report
Form 4 EyePoint Pharmaceuticals For: Feb 09 Filed by: Lurker Nancy
2/13
05:39 pm
eypt
Form 4 EyePoint Pharmaceuticals For: Feb 09 Filed by: Elston George
Low
Report
Form 4 EyePoint Pharmaceuticals For: Feb 09 Filed by: Elston George
2/13
05:39 pm
eypt
Form 4 EyePoint Pharmaceuticals For: Feb 09 Filed by: Jones David Scott
Low
Report
Form 4 EyePoint Pharmaceuticals For: Feb 09 Filed by: Jones David Scott
2/13
05:39 pm
eypt
Form 4 EyePoint Pharmaceuticals For: Feb 09 Filed by: Paggiarino Dario A.
Low
Report
Form 4 EyePoint Pharmaceuticals For: Feb 09 Filed by: Paggiarino Dario A.
2/13
05:38 pm
eypt
Form 4 EyePoint Pharmaceuticals For: Feb 09 Filed by: Duker Jay S.
Low
Report
Form 4 EyePoint Pharmaceuticals For: Feb 09 Filed by: Duker Jay S.
2/13
12:00 pm
eypt
Form SC 13G/A EyePoint Pharmaceuticals Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
Low
Report
Form SC 13G/A EyePoint Pharmaceuticals Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
2/7
07:55 am
eypt
Form SC 13G/A EyePoint Pharmaceuticals Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Medium
Report
Form SC 13G/A EyePoint Pharmaceuticals Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
2/6
10:55 am
eypt
Form SC 13G/A EyePoint Pharmaceuticals Filed by: FRANKLIN RESOURCES INC
Low
Report
Form SC 13G/A EyePoint Pharmaceuticals Filed by: FRANKLIN RESOURCES INC
2/5
05:16 pm
eypt
Form 4 EyePoint Pharmaceuticals For: Feb 02 Filed by: Jones David Scott
Medium
Report
Form 4 EyePoint Pharmaceuticals For: Feb 02 Filed by: Jones David Scott
2/2
04:23 pm
eypt
Form 144 EyePoint Pharmaceuticals Filed by: Jones David Scott
Medium
Report
Form 144 EyePoint Pharmaceuticals Filed by: Jones David Scott
1/30
04:53 pm
eypt
Form 4 EyePoint Pharmaceuticals For: Jan 26 Filed by: Paggiarino Dario A.
Medium
Report
Form 4 EyePoint Pharmaceuticals For: Jan 26 Filed by: Paggiarino Dario A.
1/29
05:54 pm
eypt
Form 4 EyePoint Pharmaceuticals For: Jan 26 Filed by: Jones David Scott
Medium
Report
Form 4 EyePoint Pharmaceuticals For: Jan 26 Filed by: Jones David Scott
1/29
05:52 pm
eypt
Form 4 EyePoint Pharmaceuticals For: Jan 25 Filed by: Paggiarino Dario A.
Medium
Report
Form 4 EyePoint Pharmaceuticals For: Jan 25 Filed by: Paggiarino Dario A.
1/26
05:04 pm
eypt
Form 4 EyePoint Pharmaceuticals For: Jan 24 Filed by: Jones David Scott
Low
Report
Form 4 EyePoint Pharmaceuticals For: Jan 24 Filed by: Jones David Scott
1/25
06:26 pm
eypt
Form 4 EyePoint Pharmaceuticals For: Jan 23 Filed by: Paggiarino Dario A.
Medium
Report
Form 4 EyePoint Pharmaceuticals For: Jan 23 Filed by: Paggiarino Dario A.